Lakewood-Amedex Biotherapeutics Inc. S-1/A Filing
Ticker: LABT · Form: S-1/A · Filed: 2026-04-01T06:20:52-04:00
Sentiment: neutral
From the Filing
EDGAR Filing Documents for 0001213900-26-037938 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] SEC Accession No. 0001213900-26-037938 Filing Date 2026-04-01 Accepted 2026-04-01 06:20:52 Documents 18 Document Format Files Seq Description Document Type Size 1 REGISTRATION STATEMENT ea0248668-12.htm S-1/A 6835823 2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea024866812ex23-1.htm EX-23.1 1906 3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea024866812ex23-2.htm EX-23.2 1692 4 GRAPHIC timage_001.jpg GRAPHIC 559860 5 GRAPHIC tbarchart_001.jpg GRAPHIC 136287 6 GRAPHIC timage_002.jpg GRAPHIC 232945 7 GRAPHIC tlinechart_001.jpg GRAPHIC 358641 8 GRAPHIC timage_003.jpg GRAPHIC 355200 9 GRAPHIC timage_004.jpg GRAPHIC 386532 10 GRAPHIC timage_005.jpg GRAPHIC 435579 11 GRAPHIC tbarchart_002.jpg GRAPHIC 391982 12 GRAPHIC tbarchart_003.jpg GRAPHIC 415704 13 GRAPHIC tbarchart_004.jpg GRAPHIC 301195 14 GRAPHIC tbarchart_009.jpg GRAPHIC 315113 15 GRAPHIC tbarchart_005.jpg GRAPHIC 371265 16 GRAPHIC tbarchart_006.jpg GRAPHIC 258646 17 GRAPHIC tbarchart_007.jpg GRAPHIC 237466 18 GRAPHIC tbarchart_008.jpg GRAPHIC 272899 Complete submission text file 0001213900-26-037938.txt 13768991 Mailing Address 8031 COOPER CREEK BLVD. SUITE 103 UNIVERSITY PARK FL 34201 Business Address 8031 COOPER CREEK BLVD. SUITE 103 UNIVERSITY PARK FL 34201 9412252515 Lakewood-Amedex Biotherapeutics Inc. (Filer) CIK : 0002079272 (see all company filings) EIN. : 205274304 | State of Incorp.: NV | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)